Research Article
Plasma C1q/TNF-Related Protein-3 (CTRP-3) and High-Mobility Group Box-1 (HMGB-1) Concentrations in Subjects with Prediabetes and Type 2 Diabetes
Table 1
Clinical and biochemical characteristics of the study subjects.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data were expressed as means ± standard deviation. Nonnormally distributed parameters including LDL-C and γ-GGT were logarithmically transformed before analyses. Differences between multiple groups were tested by analysis of variance (ANOVA) for continuous variables. NGT, normal glucose tolerance; pre-DM, prediabetes states (including IFG, impaired fasting glucose; IGT, impaired glucose tolerance; IGR, impaired glucose regulation); T2DM, type 2 diabetes mellitus; M, male; F, female; FPG, fasting plasma glucose; FINS, fasting serum insulin; HOMA-IR, homeostasis model assessment for insulin resistance; 2 h PG, 2 h postchallenge plasma glucose; HbA1c, hemoglobin A1c; BMI, body mass index; WHR, waist-to-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; AST, aspartate transaminase; ALT, alanine transaminase; γ-GGT, gamma-glutamyl transpeptidase; IL-6, interleukin-6. #Logarithmically transformed variables. compared with NGT, compared with pre-DM. |